Endo International plc: ENDO REPORTS THIRD-QUARTER 2022 FINA

DUBLIN, Nov. 9, 2022 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) today reported financial results for the third-quarter ended September 30, 2022. THIRD-QUARTER FINANCIAL PERFORMANCE (in

Related Keywords

Canada , Dublin , Ireland , Canadian , , Prnewswire Endo International , Branded Pharmaceuticals , Paladin Labs Inc , Linkedin , Generic Pharmaceuticals , Endo Investor Relations Department , Exchange Commission , International Pharmaceuticals , Pfizer Inc , Company Loss , Company Chapter , Months Ended September , Diluted Net Loss , Diluted Net Income , Continuing Operations , Adjusted Diluted Weighted Average Shares , Adjusted Income , Adjusted Diluted Net Income , Quarterly Report , Sterile Injectables , Specialty Products , Note Regarding Forward Looking Statements , Paladin Labs , Condensed Consolidated Statement , Condensed Consolidated Balance Sheet , Cash Flow , Qualified Settlement , Current Report , Supplemental Financial Information , Condensed Consolidated Statements , Accounting Standards Codification Topic , Private Securities Litigation Reform Act , Bankruptcy Code , Annual Report , Quarterly Reports , Astraendo , Nternational , Undo , Reports , Third , Quarter , 022 , Financial , Results ,